XMRV Infection in Patients With Prostate Cancer: Novel Serologic Assay and Correlation With PCR and FISH

Urology

Volumn 75, Issue 4, 2010, Pages 755-761

  Arnold, Rebecca S ^a,b   Makarova, Natalia V ^c   Osunkoya, Adeboye O ^a,b   Suppiah, Suganthi ^a   Scott, Takara A ^a   Johnson, Nicole A ^a   Bhosle, Sushma M ^a   Liotta, Dennis ^a   Hunter, Eric ^a,c   Marshall, Fray F ^a   Ly, Hinh ^a   Molinaro, Ross J ^a   Blackwell, Jerry L ^a,c   Petros, John A ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DNA DETERMINATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENOTYPE; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RETROVIRUS; RETROVIRUS INFECTION; SEROLOGY; VIRUS DETECTION; XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS; XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS INFECTION;

ADULT; AGED; ANTIBODIES, NEUTRALIZING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA VIRUS, MURINE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; RETROVIRIDAE INFECTIONS; SEROLOGIC TESTS; TUMOR VIRUS INFECTIONS;

EID: 77950226521     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.01.038     Document Type: Article

References (11)

1. Urisman A., Molinaro R.J., Fischer N., et al. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2 (2006) e25 -e25
2. Fischer N., Hellwinkel O., Schulz C., et al. Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol 43 (2008) 277-283
3. Schlaberg R., Choe D.J., Brown K.R., et al. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci USA 106 (2009) 16351-16356
4. Hohn O., Krause H., Barbarotto P., et al. Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology 6 (2009) 92 -92
5. Hong S., Klein E.A., Das Gupta J., et al. Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancer. J Virol 83 (2009) 6995-7003
6. Montefiori D.C., Metch B., McElrath M.J., et al. Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines. J Infect Dis 190 (2004) 1962-1969
7. Platt E.J., Wehrly K., Kuhmann S.E., et al. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 72 (1998) 2855-2864
8. Meng G., Wei X., Wu X., et al. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nat Med 8 (2002) 150-156
9. Wei X., Decker J.M., Liu H., et al. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 46 (2002) 1896-1905
10. Li B., Decker J.M., Johnson R.W., et al. Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1. J Virol 80 (2006) 5211-5218
11. Burkhart M.D., D'Agostino P., Kayman S.C., et al. Involvement of the C-terminal disulfide-bonded loop of murine leukemia virus SU protein in a postbinding step critical for viral entry. J Virol 79 (2005) 7868-7876